You are receiving this message as a subscriber to the FDA HIV/AIDS electronic list serve. The purpose of the list serve is to relay important information about HIV/AIDS-related products and issues, including product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings and alerts to proposed regulatory guidances for comment.
Please do not reply to this message.
On June 17, 2014, The Forum for Collaborative HIV Research will host an all-day workshop in Washington, DC at the Kaiser Family Foundation's Barbara Jordan Conference Center as part of an ongoing, open process to seek input from the broader HIV community on specific regulatory issues in cure research - such as acceptable risk, ethics, informed consent and appropriate populations.
The workshop is a collaboration between The Forum, NIH, and FDA, and will involve community, industry and academia.
The June 17th workshop will be open to the public and simultaneously webcast.
To participate, either in person or via webcast, you will need to register through the link you will find at http://www.hivforum.org/projects/cross-cutting-topics/118-cross-cutting-topics/581-cure
Richard Klein
Office of Health and Constituent Affairs
Food and Drug Administration
Kimberly Struble
Division of Antiviral Products
Food and Drug Administration
Steve Morin
Office of Health and Constituent Affairs
Food and Drug Administration
| This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
